These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
359 related items for PubMed ID: 27261523
1. Flutriciclamide (18F-GE180) PET: First-in-Human PET Study of Novel Third-Generation In Vivo Marker of Human Translocator Protein. Fan Z, Calsolaro V, Atkinson RA, Femminella GD, Waldman A, Buckley C, Trigg W, Brooks DJ, Hinz R, Edison P. J Nucl Med; 2016 Nov; 57(11):1753-1759. PubMed ID: 27261523 [Abstract] [Full Text] [Related]
2. Kinetic analysis of the translocator protein positron emission tomography ligand [18F]GE-180 in the human brain. Feeney C, Scott G, Raffel J, Roberts S, Coello C, Jolly A, Searle G, Goldstone AP, Brooks DJ, Nicholas RS, Trigg W, Gunn RN, Sharp DJ. Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2201-2210. PubMed ID: 27349244 [Abstract] [Full Text] [Related]
3. Head-to-Head Comparison of 11C-PBR28 and 18F-GE180 for Quantification of the Translocator Protein in the Human Brain. Zanotti-Fregonara P, Pascual B, Rizzo G, Yu M, Pal N, Beers D, Carter R, Appel SH, Atassi N, Masdeu JC. J Nucl Med; 2018 Aug; 59(8):1260-1266. PubMed ID: 29348317 [Abstract] [Full Text] [Related]
4. In Vivo Detection of Age- and Disease-Related Increases in Neuroinflammation by 18F-GE180 TSPO MicroPET Imaging in Wild-Type and Alzheimer's Transgenic Mice. Liu B, Le KX, Park MA, Wang S, Belanger AP, Dubey S, Frost JL, Holton P, Reiser V, Jones PA, Trigg W, Di Carli MF, Lemere CA. J Neurosci; 2015 Nov 25; 35(47):15716-30. PubMed ID: 26609163 [Abstract] [Full Text] [Related]
5. Pharmacokinetic Evaluation of the Tau PET Radiotracer 18F-T807 (18F-AV-1451) in Human Subjects. Wooten DW, Guehl NJ, Verwer EE, Shoup TM, Yokell DL, Zubcevik N, Vasdev N, Zafonte RD, Johnson KA, El Fakhri G, Normandin MD. J Nucl Med; 2017 Mar 25; 58(3):484-491. PubMed ID: 27660144 [Abstract] [Full Text] [Related]
6. Quantitative assessment of translocator protein (TSPO) in the non-human primate brain and clinical translation of [18F]LW223 as a TSPO-targeted PET radioligand. Tan Z, Haider A, Zhang S, Chen J, Wei J, Liao K, Li G, Wei H, Dong C, Ran W, Li Y, Li Y, Rong J, Li Y, Liang SH, Xu H, Wang L. Pharmacol Res; 2023 Mar 25; 189():106681. PubMed ID: 36746361 [Abstract] [Full Text] [Related]
7. Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180. Chau WF, Black AM, Clarke A, Durrant C, Gausemel I, Khan I, Mantzilas D, Oulie I, Rogstad A, Trigg W, Jones PA. Nucl Med Biol; 2015 Sep 25; 42(9):711-9. PubMed ID: 26072270 [Abstract] [Full Text] [Related]
8. Preclinical Evaluation and Quantification of 18F-Fluoroethyl and 18F-Fluoropropyl Analogs of SCH442416 as Radioligands for PET Imaging of the Adenosine A2A Receptor in Rat Brain. Khanapur S, van Waarde A, Dierckx RA, Elsinga PH, Koole MJ. J Nucl Med; 2017 Mar 25; 58(3):466-472. PubMed ID: 27789720 [Abstract] [Full Text] [Related]
9. Reliable quantification of 18F-GE-180 PET neuroinflammation studies using an individually scaled population-based input function or late tissue-to-blood ratio. Buchert R, Dirks M, Schütze C, Wilke F, Mamach M, Wirries AK, Pflugrad H, Hamann L, Langer LBN, Wetzel C, Lukacevic M, Polyak A, Kessler M, Petrusch C, Bengel FM, Geworski L, Rupprecht R, Weissenborn K, Ross TL, Berding G. Eur J Nucl Med Mol Imaging; 2020 Nov 25; 47(12):2887-2900. PubMed ID: 32322915 [Abstract] [Full Text] [Related]
10. Quantification of the specific translocator protein signal of 18F-PBR111 in healthy humans: a genetic polymorphism effect on in vivo binding. Guo Q, Colasanti A, Owen DR, Onega M, Kamalakaran A, Bennacef I, Matthews PM, Rabiner EA, Turkheimer FE, Gunn RN. J Nucl Med; 2013 Nov 25; 54(11):1915-23. PubMed ID: 24071511 [Abstract] [Full Text] [Related]
11. Coupling between physiological TSPO expression in brain and myocardium allows stabilization of late-phase cerebral [18F]GE180 PET quantification. Deussing M, Blume T, Vomacka L, Mahler C, Focke C, Todica A, Unterrainer M, Albert NL, Lindner S, von Ungern-Sternberg B, Baumann K, Zwergal A, Bartenstein P, Herms J, Rominger A, Brendel M. Neuroimage; 2018 Jan 15; 165():83-91. PubMed ID: 28988133 [Abstract] [Full Text] [Related]
12. The Variability of Translocator Protein Signal in Brain and Blood of Genotyped Healthy Humans Using In Vivo 123I-CLINDE SPECT Imaging: A Test-Retest Study. Feng L, Jensen P, Thomsen G, Dyssegaard A, Svarer C, Knudsen LV, Møller K, Thomsen C, Mikkelsen JD, Guilloteau D, Knudsen GM, Pinborg LH. J Nucl Med; 2017 Jun 15; 58(6):989-995. PubMed ID: 28572290 [Abstract] [Full Text] [Related]
13. Machine learning-based approach reveals essential features for simplified TSPO PET quantification in ischemic stroke patients. Zatcepin A, Kopczak A, Holzgreve A, Hein S, Schindler A, Duering M, Kaiser L, Lindner S, Schidlowski M, Bartenstein P, Albert N, Brendel M, Ziegler SI. Z Med Phys; 2024 May 15; 34(2):218-230. PubMed ID: 36682921 [Abstract] [Full Text] [Related]
14. Preclinical in vivo and in vitro comparison of the translocator protein PET ligands [18F]PBR102 and [18F]PBR111. Eberl S, Katsifis A, Peyronneau MA, Wen L, Henderson D, Loc'h C, Greguric I, Verschuer J, Pham T, Lam P, Mattner F, Mohamed A, Fulham MJ. Eur J Nucl Med Mol Imaging; 2017 Feb 15; 44(2):296-307. PubMed ID: 27699720 [Abstract] [Full Text] [Related]
15. Impact of Endothelial 18-kDa Translocator Protein on the Quantification of 18F-DPA-714. Wimberley C, Lavisse S, Brulon V, Peyronneau MA, Leroy C, Bodini B, Remy P, Stankoff B, Buvat I, Bottlaender M. J Nucl Med; 2018 Feb 15; 59(2):307-314. PubMed ID: 28775204 [Abstract] [Full Text] [Related]
16. Optimized Quantification of Translocator Protein Radioligand ¹⁸F-DPA-714 Uptake in the Brain of Genotyped Healthy Volunteers. Lavisse S, García-Lorenzo D, Peyronneau MA, Bodini B, Thiriez C, Kuhnast B, Comtat C, Remy P, Stankoff B, Bottlaender M. J Nucl Med; 2015 Jul 15; 56(7):1048-54. PubMed ID: 26025960 [Abstract] [Full Text] [Related]
17. 11C-ER176, a Radioligand for 18-kDa Translocator Protein, Has Adequate Sensitivity to Robustly Image All Three Affinity Genotypes in Human Brain. Ikawa M, Lohith TG, Shrestha S, Telu S, Zoghbi SS, Castellano S, Taliani S, Da Settimo F, Fujita M, Pike VW, Innis RB, Biomarkers Consortium Radioligand Project Team. J Nucl Med; 2017 Feb 15; 58(2):320-325. PubMed ID: 27856631 [Abstract] [Full Text] [Related]
18. Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [18F]GE-180: a Blocking Study Using XBD173 in Multiple Sclerosis Normal Appearing White and Grey Matter. Sridharan S, Raffel J, Nandoskar A, Record C, Brooks DJ, Owen D, Sharp D, Muraro PA, Gunn R, Nicholas R. Mol Imaging Biol; 2019 Oct 15; 21(5):935-944. PubMed ID: 30796709 [Abstract] [Full Text] [Related]
19. In Vivo Evaluation of 6 Analogs of 11C-ER176 as Candidate 18F-Labeled Radioligands for 18-kDa Translocator Protein. Lee JH, Siméon FG, Liow JS, Morse CL, Gladding RL, Santamaria JAM, Henter ID, Zoghbi SS, Pike VW, Innis RB. J Nucl Med; 2022 Aug 15; 63(8):1252-1258. PubMed ID: 35027372 [Abstract] [Full Text] [Related]
20. Quantitative imaging of neuroinflammation in human white matter: a positron emission tomography study with translocator protein 18 kDa radioligand, [18F]-FEPPA. Suridjan I, Rusjan PM, Kenk M, Verhoeff NP, Voineskos AN, Rotenberg D, Wilson AA, Meyer JH, Houle S, Mizrahi R. Synapse; 2014 Nov 15; 68(11):536-47. PubMed ID: 25043159 [Abstract] [Full Text] [Related] Page: [Next] [New Search]